Though there were no CADRs in the HLA-B*15:02 positive group, CBZ-induced SJS/TEN were reported from HLA-B*15:02 carriers who received CBZ without PGx screening before prescription. This evidence concerns the gene HLA-B and toxic epidermal necrolysis.